Table 1.
Baseline demographic and immunological parameters of study participants
| Parameters | HIV/HCV co-infection |
HIV mono-infection |
HCV mono-infection |
Healthy control |
|---|---|---|---|---|
| Number | 20 | 20 | 10 | 10 |
| Sex ratio (male/female) | 13/7 | 12/8 | 7/3 | 4/6 |
| Age (years) | 39.00 (35.25 ~ 41.50) c, d |
37.00 (32.75 ~ 41.50) c, d |
45.50 (39.50 ~ 48.50) a, b, d |
26.50 (25.00 ~ 29.25) a, b, c |
| Transmission route (no. (%)) |
||||
| Sex | 0 (0) | 12 (60) | 0 (0) | - |
| Blood | 4 (20) | 1 (5) | 10 (100) | - |
| IDU | 16 (80) | 4 (20) | 0 (0) | - |
| Unknown | 0 (0) | 3 (15) | 0 (0) | - |
| CD4 T cell count (cells/μl) | 224.00 (164.00 ~ 296.00) b, c, d |
131.00 (73.75 ~ 194.50) a, c, d |
522.50 (448.00 ~ 599.00) a, b, d |
817.00 (736.00 ~ 947.25) a, b, c |
| HIV-1 Viral load (log10 copies/ml) |
3.97(3.48 ~ 4.83) b | 4.65(4.38 ~ 5.23) a | - | - |
| HCV Viral load (log10 copies/ml) |
6.42(5.91 ~ 6.85) | - | 6.05(5.33 ~ 6.54) | - |
a. p < 0.05 difference when compared to HIV/HCV co-infection
b. p < 0.05 difference when compared to HIV mono-infection
c. p < 0.05 difference when compared to HCV mono-infection
d. p < 0.05 difference when compared to healthy control